company

University of Oxford

as of 2026-07-01
Monitor thisAsk about this
at a glance
10 trials sponsored · 10 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

10 assets
CannabidiolCitalopramIndividual placement and support (vocational rehabilitation)Intravenous immunoglobulinMaltodextrinPlacebPlasma ExchangeQualitative interviewRituximabprebiotics

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Cannabidiol
small molecule
drug
Citalopram
small molecule
drug
Individual placement and support (vocational rehabilitation)
PROCEDURE
drug
Intravenous immunoglobulin
small molecule
drug
Maltodextrin
DIETARY_SUPPLEMENT
drug
Placeb
small molecule
drug
Plasma Exchange
BIOLOGICAL
drug
Qualitative interview
OTHER
drug